Papers

214 results
Association between interleukin-12 +1188A/C polymorphism and the risk of tuberculosis: A meta-analysis.
Wang P, Liao J - African health sciences, January 15, 2024 0 citations
P
EMBASE, PubMed
I/C
retrospective analysis, random- or fixed-effects model
O
combined odds ratios (ORs)
Systematic review and meta-analysis of Mycobacterium avium subsp. paratuberculosis as environmental trigger of multiple sclerosis.
Ekundayo TC, Olasehinde TA, Falade AO, Adewoyin MA, Iwu CD, Igere BE, Ijabadeniyi OA - Multiple sclerosis and related disorders, February 19, 2022 11 citations
P
2,538
I/C
MAP-related MS data, Random-effects (RE) and fixed-effects (FE) meta-analytic models
O
Odd ratios (ORs) associated with MAP with the risk of MS
Association between epilepsy and risk of depression: A meta-analysis.
Chu C - Psychiatry research, April 13, 2022 9 citations
P
epilepsy patients
I/C
search for articles published in Web of Science, Google Scholar and PubMed, computation of odds ratios (ORs)/relative risks (RRs) using STATA 12.0 software
O
association between epilepsy and risk of depression
Red and processed meat intake and risk of cardiovascular disease: A two-sample Mendelian randomization study.
Hu B, He X, Sun H, Hu Y, Li F, Sun Y, Sun J, Feng L - Clinical nutrition ESPEN, March 14, 2024 0 citations
P
red meat, processed meat
I/C
genetically predicted red and processed meat consumption, no significant causal relationships
O
the risk of the four CVD outcomes examined
Gait and fate: Baseline gait speed and mortality after transcatheter aortic valve implantation.
Takagi H, Kato M, Hari Y, Nakashima K, Kuno T, Ando T, null null - Journal of cardiology, February 27, 2020 4 citations
P
slow walkers, unable to walk
I/C
TAVI, fast walkers, walkers
O
mortality
5-HTTLPR polymorphism and depression risk in Parkinson's disease: an updated meta-analysis.
Cheng P, Zhang J, Wu Y, Liu W, Zhu J, Chen Z, Zhang J, Guan S, Sun Y, Wang J - Acta neurologica Belgica, March 29, 2020 7 citations
P
PD patients
I/C
5-HTTLPR genotype (S/S-Allele), PD patients without depression
O
Depression risk
Mortality Risk After Radioiodine Therapy for Hyperthyroidism: A Systematic Review and Meta-Analysis.
Yan D, Chen C, Yan H, Liu T, Yan H, Yuan J - Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, February 23, 2021 5 citations
P
patients with hyperthyroidism
I/C
radioiodine treatment, no treatment or other treatments
O
mortality, all-cause mortality, circulatory diseases mortality, respiratory diseases mortality, endocrine and metabolic diseases mortality, cancer mortality
Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis.
Yang S, Xu Y, Zhang Y, Li D, Li X - Current pharmaceutical design, March 25, 2024 0 citations
P
Oral anticoagulants (OAC), P-glycoprotein (P-gp)/CYP3A4 enzyme
I/C
P-gp/CYP3A4 inhibitors, Rivaroxaban, Dabigatran, Apixaban, Edoxaban, Warfarin
O
Major bleeding, Gastrointestinal (GI) bleeding, Stroke/systemic embolism (SE), All-cause mortality, Any bleeding, Intracranial hemorrhage (ICH)
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M, Edwards S, Noel-Storr AH, McCleery J, Myint PK, Soiza R, Stewart C, Loke YK, Quinn TJ - The Cochrane database of systematic reviews, June 08, 2021 21 citations
P
older adults without cognitive impairment
I/C
anticholinergic medications, cognitive decline or dementia
O
risk of cognitive decline or dementia
Association of Polymorphism rs1045411 in the HMGB1 Gene with Cancer Risk: Evidence from a Meta-analysis.
Xia Q, Tao P, Xu J - International journal of medical sciences, February 26, 2021 1 citations
P
3,918 cases, 5,296 controls
I/C
HMGB1 rs1045411 polymorphism, TT genotype vs. non-TT genotype
O
Increased cancer risk
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.